WESTFIELD CAPITAL MANAGEMENT CO LP – Blueprint Medicines Corporation Transaction History
WESTFIELD CAPITAL MANAGEMENT CO LP portfolio value:
$52.95M
portfolio value
WESTFIELD CAPITAL MANAGEMENT CO LP quarter portfolio value change:
+30.45%
quarter
Blueprint Medicines Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -41.97% | -581.16K shares | -16.99M | $65.89 | 803.64K |
| Q2 2022 | share | Increase | +18.01% | 211.38K shares | -5.01M | $50.51 | 1.38M |
| Q1 2022 | share | Increase | +6.80% | 74.73K shares | -42.72M | $63.88 | 1.17M |
| Q4 2021 | share | Decrease | -9.60% | -116.66K shares | -7.26M | $109.45 | 1.09M |
| Q3 2021 | share | Increase | +2.99% | 35.23K shares | 21.14M | $102.81 | 1.21M |
| Q2 2021 | share | Increase | +4.58% | 51.63K shares | -5.92M | $87.96 | 1.18M |
| Q1 2021 | share | Increase | +30.00% | 260.42K shares | 12.36M | $97.23 | 1.12M |
| Q4 2020 | share | Decrease | -18.17% | -192.73K shares | -982K | $112.15 | 868.06K |
| Q3 2020 | share | Increase | +0.82% | 8.61K shares | 16.26M | $92.7 | 1.06M |
| Q2 2020 | share | Increase | +2.69% | 27.57K shares | 22.15M | $78 | 1.05M |
| Q1 2020 | share | Increase | +32.96% | 253.97K shares | -1.81M | $58.48 | 1.02M |
| Q4 2019 | share | Decrease | -9.01% | -76.32K shares | -490K | $80.11 | 770.63K |
| Q3 2019 | share | Increase | +38.31% | 234.57K shares | 4.46M | $73.47 | 846.95K |
| Q2 2019 | share | Increase | +31.12% | 145.33K shares | 20.37M | $94.33 | 612.38K |
| Q1 2019 | share | Decrease | -19.87% | -115.78K shares | 5.96M | $80.05 | 467.04K |
| Q4 2018 | share | Increase | +14.42% | 73.44K shares | -8.34M | $53.91 | 582.82K |
| Q3 2018 | share | Increase | +139.17% | 296.4K shares | 26.24M | $78.06 | 509.38K |
| Q2 2018 | share | Increase | 0.00% | 212.98K shares | 13.52M | $63.48 | 212.98K |